Population Genomic Screening: Toward a Future Standard of Care with Miranda Hallquist, CGC, M.Sc

• There are an expanding number of research and clinical programs identifying genomic variants in individuals unselected for personal or family health history. Returning clinically actionable genomic results to patient-participants provides an opportunity to tailor their health care to facilitate prevention, early detection, and treatment strategies. This webinar will review the current landscape of population genomic screening and highlight gaps in current knowledge and implementation. The discussion will highlight where further research is needed and potential barriers to patients accessing genomic screening.

  Level of Instruction: Intermediate

  

  Only the live session qualifies for CEUs but when possible, we host the recordings on our website and NSGC recommends participants to use their personal email instead of work email addresses to ensure they receive their CEU certificates.

  

  Ambry Genetics is approved as a provider for continuing education program by NSGC and ASCLS P.A.C.E ® Program.

Miranda Hallquist, CGC, M.Sc | Presenter

Senior Genetic Counselor, Geisinger & Director of Geisinger’s Genetic Counseling Assistant Program

Miranda Hallquist received her MSc in Genetic Counseling from the University of Toronto in 2006. After spending a few years as a full-time mom, she practiced clinical cancer genetic counseling for over seven years before transitioning to full time research. Miranda’s research interests surround increasing access to genomic information to guide health care decisions. She’s particularly interested in genetic counseling practice and population genomic screening. Miranda is currently a Senior Genetic Counselor at Geisinger and Director of Geisinger’s Genetic Counseling Assistant Program.

Rachel Bluebond, MMSc, CGC | Moderator

Genomic Science Liaison, Ambry Genetics

Rachel Bluebond joined Ambry in 2020 as the Oncology Genomic Science Liaison for the South Central Region. In her current role she serves as a clinical liaison for the field team to educate health care providers and key opinion leaders on genetic testing and genomic medicine. Rachel previously worked as a clinical oncology genetic counselor at the University of Texas MD Anderson Cancer Center in Houston, Texas for 7 years and has worked with PWNHealth providing telehealth genetic counseling for 4 years. Rachel has been involved in graduate education at the UT MD Anderson UT Houston School of Biomedical Sciences. She is a member of the National Society of Genetic Counselors and the chair of the Billing Workgroup of the Access and Service Delivery Committee. Rachel received her Master of Medical Science degree in Human Genetics and Genetic Counseling from Emory University, and is certified by the American Board of Genetic Counseling.